OUR opportUNIties
…healing

TU Dresden is my Uni because we deliver the latest research findings straight to the patient. Here, we combine innovative teaching and international research with the closest possible proximity to patients for the personalised medicine of tomorrow.

The Medical Faculty of TU Dresden and the Dresden University Hospital bring together nationally and internationally renowned centres of experts, allowing us to provide our patients with the highest level of care. To me, this work is both meaningful and hugely exciting.

From 2010 to 2017, I studied human medicine at TU Dresden. During my studies, I already worked intensively at the Institute of Pharmacology and Toxicology, and I have been working here as head of a working group since 2018.

My working group focusses on researching new drugs to stop or reverse the pathological proliferation of connective tissue in organs, also known as fibrosis. Fibrosis can affect all organs and is to a certain extent a sign of ageing in the body. However, if the processes involved become unbalanced, this will have serious consequences for the patient. For example, chronic heart failure can develop. That is why, in view of an increasingly ageing population, we are devoting ourselves to the development of new and, above all, tailor-made drug therapies.

To this end, we work together, among others, with the Dresden Clinic and Polyclinic for Gynaecology and Obstetrics, the BTU Cottbus-Senftenberg and King’s College London, as part of the transCampus. These collaborations enable us to combine know-how from the fields of molecular biology, proteomics, cell physiology and pharmacology.

TU Dresden is my Uni because we deliver the latest research findings straight to the patient. Here, we combine innovative teaching and international research with the closest possible proximity to patients for the personalised medicine of tomorrow.

The Medical Faculty of TU Dresden and the Dresden University Hospital bring together nationally and internationally renowned centres of experts, allowing us to provide our patients with the highest level of care. To me, this work is both meaningful and hugely exciting.

From 2010 to 2017, I studied human medicine at TU Dresden. During my studies, I already worked intensively at the Institute of Pharmacology and Toxicology, and I have been working here as head of a working group since 2018.

My working group focusses on researching new drugs to stop or reverse the pathological proliferation of connective tissue in organs, also known as fibrosis. Fibrosis can affect all organs and is to a certain extent a sign of ageing in the body. However, if the processes involved become unbalanced, this will have serious consequences for the patient. For example, chronic heart failure can develop. That is why, in view of an increasingly ageing population, we are devoting ourselves to the development of new and, above all, tailor-made drug therapies.

To this end, we work together, among others, with the Dresden Clinic and Polyclinic for Gynaecology and Obstetrics, the BTU Cottbus-Senftenberg and King’s College London, as part of the transCampus. These collaborations enable us to combine know-how from the fields of molecular biology, proteomics, cell physiology and pharmacology.

Dr.
Stephan
Künzel
Assistant Physician and Junior Research Group Leader at the Medical Faculty
share
mehr lesen

TU Dresden is my Uni because we deliver the latest research findings straight to the patient. Here, we combine innovative teaching and international research with the closest possible proximity to patients for the personalised medicine of tomorrow.

The Medical Faculty of TU Dresden and the Dresden University Hospital bring together nationally and internationally renowned centres of experts, allowing us to provide our patients with the highest level of care. To me, this work is both meaningful and hugely exciting.

From 2010 to 2017, I studied human medicine at TU Dresden. During my studies, I already worked intensively at the Institute of Pharmacology and Toxicology, and I have been working here as head of a working group since 2018.

My working group focusses on researching new drugs to stop or reverse the pathological proliferation of connective tissue in organs, also known as fibrosis. Fibrosis can affect all organs and is to a certain extent a sign of ageing in the body. However, if the processes involved become unbalanced, this will have serious consequences for the patient. For example, chronic heart failure can develop. That is why, in view of an increasingly ageing population, we are devoting ourselves to the development of new and, above all, tailor-made drug therapies.

To this end, we work together, among others, with the Dresden Clinic and Polyclinic for Gynaecology and Obstetrics, the BTU Cottbus-Senftenberg and King’s College London, as part of the transCampus. These collaborations enable us to combine know-how from the fields of molecular biology, proteomics, cell physiology and pharmacology.

Dr.
Stephan
Künzel
Assistant Physician and Junior Research Group Leader at the Medical Faculty
share